DocGo Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- DocGo Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $684.00, a 99.90% decline year-over-year.
- DocGo Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $426.00K, a 41.52% decline year-over-year.
- DocGo Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $706.40K, a 9.33% decline year-over-year.
- DocGo Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $249.72K, a 33.29% decline year-over-year.
- DocGo Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $26.33K, a 98.14% decline from fiscal 2023.
- DocGo Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $1.41M, a 28.61% decline from fiscal 2022.
- DocGo Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $1.98M, a 215.11% increase from fiscal 2021.
- DocGo Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $628.59K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $26.33K 10-K · filed 2026-03-16 | |
| 2024-06-30 | $684.00 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $1.41M 10-K · filed 2026-03-16 | |
| 2023-09-30 | $426.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $706.40K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $249.72K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $1.98M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $728.50K 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $779.07K 10-Q · filed 2023-11-06 | |
| 2022-03-31 | $374.34K 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $628.59K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |